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Background: The depletion of fossil fuels and the rising need to meet global energy demands have led to a
growing interest in microbial biofuel synthesis, particularly in Escherichia coli, due to its tractable characteristics.
Besides engineering more efficient metabolic pathways for synthesizing biofuels, efforts to improve production
yield by engineering efflux systems to overcome toxicity problems is also crucial. This study aims to enhance
hydrocarbon efflux capability in E. coli by engineering a native inner membrane transporter, AcrB, using the
directed evolution approach.
Results: We developed a selection platform based on competitive growth using a toxic substrate surrogate, which
allowed rapid selection of AcrB variants showing enhanced efflux of linear and cyclic fuel molecule candidates, n-
octane and α-pinene. Two mutants exhibiting increased efflux efficiency for n-octane and α-pinene by up to 47%
and 400%, respectively, were isolated. Single-site mutants based on the mutations found in the isolated variants
were synthesized and the amino acid substitutions N189H, T678S, Q737L and M844L were identified to have
conferred improvement in efflux efficiency. The locations of beneficial mutations in AcrB suggest their contributions
in widening the substrate channel, altering the dynamics of substrate efflux and promoting the assembly of AcrB
with the outer membrane channel protein TolC for more efficient substrate export. It is interesting to note that
three of the four beneficial mutations were located relatively distant from the known substrate channels, thus
exemplifying the advantage of directed evolution over rational design.
Conclusions: Using directed evolution, we have isolated AcrB mutants with improved efflux efficiency for n-octane
and α-pinene. The utilization of such optimized native efflux pumps will increase productivity of biofuels synthesis
and alleviate toxicity and difficulties in production scale-up in current microbial platforms.
Keywords: Protein engineering, Synthetic biology, Efflux, Biofuel, Directed evolution, TransporterBackground
Worldwide industrialization has resulted in an increas-
ing global demand for energy, particularly fossil fuel. To
meet the growing energy needs and tackle escalating
environmental concerns, much effort has been directed
towards biosynthesis of biofuels from renewable sources
to substitute petroleum-based fuels [1-6]. Although
bioethanol synthesis from biorenewable feedstocks
formed the earliest success story in the biofuel arena, its
low energy density and hygroscopicity led to efforts to* Correspondence: SLeong@ntu.edu.sg
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reproduction in any medium, provided the orproduce longer chain hydrocarbons with higher energy
density and lower hygroscopicity.
Many hydrocarbons are, however, toxic to microorgan-
isms and endogenous biosynthesis of these compounds
is expected to have adverse effects on cell growth and
production yield [7]. One of the ways microorganisms
mitigate the deleterious effect of toxic compounds is to
employ efflux pumps to expel noxious molecules, hence
enhancing cell survival [8]. While cell viability may not
be a major concern for production of less toxic biofuels
such as medium and long chain alkanes [8], these efflux
pumps can help to accelerate release of the hydrocar-
bons into the growth media for harvest. Thus, utilizing
efflux pumps to complement biosynthesis of biofuelral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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production yield.
Dunlop et al. [9] recently discovered novel bacteria ef-
flux pumps that could be expressed heterologously in E.
coli to improve hydrocarbon tolerance. Although it may
seem straightforward to increase extrusion of biofuel
molecules by over-expressing the efflux pumps, this
could compromise cell viability, which is undesirable
[10]. A more favorable approach is to improve the pump
efficiency for secreting hydrocarbons. Alternatively, ef-
flux pump systems native to E. coli can be optimized for
enhanced efflux efficiency by protein engineering. The
latter strategy minimizes problems with protein aggrega-
tion and inactivity that may be associated with heterol-
ogous expression of foreign proteins [11,12], which
forms the basis of this study.
We chose to study the well-characterized AcrAB-TolC
efflux pump system, which consists of an inner mem-
brane transporter AcrB and an outer membrane channel
TolC held together by a periplasmic membrane fusion
protein AcrA [13]. It has a remarkably wide substrate
specificity, including antibiotics, dyes, detergents, as well
as many solvent molecules [13]. Since AcrB plays a crit-
ical role in substrate recognition and transport in the tri-
partite system [14], we endeavored to engineer this
protein to improve the efflux efficiency of the pump sys-
tem, particularly to accelerate the exportation of biofuel
molecules into the growth medium for easy recovery.
The target molecule chosen for this study is n-octane, a
potential fuel substitute [5,15]. To this end, we employed
directed evolution to screen for AcrB variants with im-
proved n-octane efflux rate. Unlike fluorescent sub-
strates like Nile Red [16], n-octane has no chromophore,
thus efflux rate of n-octane from E. coli cannot be con-
veniently determined spectroscopically in real time.
n-Octane is also chemically inert and difficult to deriva-
tize for colorimetric analysis. In the absence of a high-
throughput analytical method, we sought to increase the
screening throughput by competitive growth selection of
AcrB mutant pools. Based on the hypothesis that solvent
resistance correlates to increased growth and efflux rate,
subjecting E. coli cells expressing a mixture of AcrB vari-
ants to the toxicity of n-octane would enable the super-
ior mutants to dominate the population, thus enriching
the culture with AcrB mutants with improved efflux effi-
ciency. Owing to the mild toxicity of n-octane to E. coli
[8], growth selection using 1-octanol as a more toxic
substrate surrogate [17] to exert stronger selection pres-
sure was also subsequently investigated. Efflux rates of
n-octane were determined to select for variants with en-
hancement in efflux efficiency. Finally, we studied the lo-
cations of the mutations found in the selected variants
based on the reported crystal structure of AcrB (PDB
ID: 2DHH) to rationalize the possible roles that theamino acid substitutions play in improving efflux of
small biofuel molecules.
Results and discussion
Competitive growth assay for establishing conditions for
library enrichment
To identify AcrB variants with improved n-octane efflux
efficiency, we first set out to establish suitable conditions
for growth selection by determining the hydrocarbon
tolerance of E. coli K-12. To achieve this aim, the E. coli
K-12 JA300, which has been used in several studies in
solvent resistance [8,18-20], was manipulated to generate
the acrB-inactivated derivative JA300A. The acrB gene
was cloned into the low copy number plasmid pMW119
to create pAcrB. JA300A was transformed with (i) pAcrB
(for plasmid complementation) and (ii) pMW119 (for a
non-AcrB-expressing negative control strain) and exam-
ined for the inhibitory effects of n-octane and 1-octanol
on the growth rates (Figure 1). In the absence of n-octane,
JA300A/pMW119 and JA300A/pAcrB grew at very
similar rates (Figure 1a). Addition of n-octane almost
fully inhibited the growth of JA300A/pMW119 in the
biphasic culture system saturated with n-octane and
significantly retarded the proliferation of JA300A/pAcrB.
Supplementation of the growth media with 0.1 mM
isopropyl-β-D-thiogalactopyranoside (IPTG) to induce
AcrB expression markedly increased the cell growth of
JA300A/pAcrB to nearly the rate of the strains when n-oc-
tane was absent, but had no effect on JA300A/pMW119
(Figure 1a). The addition of IPTG neither enhanced nor
inhibited growth rates of JA300A/pMW119 and JA300A/
pAcrB in the absence of n-octane (Additional file 1: Figure
S1). We therefore established that competitive growth en-
richment of the mutant libraries with n-octane would be
performed at basal expression level. Under this condition,
the growth rate of cells with wild-type AcrB n-octane efflux
efficiency is sufficiently lower than the maximum growth
rate achievable by the cells. Thus, this condition applied
adequate selection pressure to enrich the culture with cells
possessing higher n-octane tolerance.
Competitive growth assays with 1-octanol were
performed with varying concentrations of the substrate
in growth media supplemented with 0.1 mM IPTG
(Figure 1b). The difference in growth rates of JA300A/
pMW119 and JA300A/pAcrB was insignificant in the
presence of 0.025% 1-octanol, although growth was
markedly inhibited for both compared to that without
1-octanol. When the 1-octanol concentration was fur-
ther increased to 0.050%, the growth of JA300A/pMW119
was more significantly inhibited than JA300A/pAcrB, with
a distinct difference in growth rate apparent between the
two strains. Thus, competitive growth enrichment of the
mutant libraries with 1-octanol was performed using in-
duced cells with 0.050% of the substrate.
Figure 1 Effects of (a) n-octane and (b) 1-octanol on the growth rates of JA300A/pMW119 (Δ) and JA300A/pAcrB (○). In (a), cell growth
in the absence of n-octane are represented by dotted lines. Dashed lines depict cell growth in the presence of n-octane without IPTG induction.
Solid lines illustrate the growth of IPTG-induced cells in the presence of n-octane. In (b), all cells were induced with IPTG. Cell growth in the
presence of 0, 0.025 and 0.050% 1-octanol are shown in solid, dotted and dashed lines, respectively. Growth of mutants 1G1 (□) and 1G2 (◊) in
0.050% 1-octanol are overlaid.
Figure 2 Plasmids isolated from a mixture of JA300A/pMW119
and JA300A/pAcrB that have been subjected to selection
conditions. AcrB was expressed at basal level in lanes 1 and 2 while
IPTG was used to induce protein expression in lanes 3 and 4. Lane 2
was subjected to growth selection with n-octane and lane 4 with
1-octanol. M denotes marker. The isolated plasmids were linearized
with BamHI and the sizes correspond to those of pAcrB (7.4 kb) and
pMW119 (4.2 kb).
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cells with higher hydrocarbon tolerance to dominate the
population in the culture was tested. JA300A/pMW119
and JA300A/pAcrB grown separately were mixed in
equal amounts and the diluted mixture was subjected to
the selection conditions for growth. Cultures with no hy-
drocarbons were grown in parallel as controls. Plasmids
isolated from the control cultures consisted of both
pMW119 and pAcrB while those extracted from cultures
grown under the selection pressure of the hydrocarbons
contained only pAcrB (Figure 2). The elimination of
non-AcrB-expressing JA300A/pMW119 under the selec-
tion conditions illustrates the successful enrichment
of the cultures with JA300A/pAcrB, which possess
higher tolerance to the hydrocarbons. These competitive
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selecting variants with improved hydrocarbon tolerance
and possibly increased efflux efficiency from an AcrB
mutant library.
Efflux rate determination of n-octane
Owing to the chemical inertness of n-octane and a lack
of chromophore, a high-throughput method for quanti-
fying n-octane was not available. Therefore, in this study,
the n-octane efflux rate was determined by a discontinu-
ous assay using gas chromatography to quantify the
intracellular n-octane over time by adaptation of
reported protocols [8,16] (Figure 3a). JA300A/pMW119
and JA300A/pAcrB were cultivated and induced with
IPTG for protein expression. AcrB, a proton-motive ef-
flux pump, was inactivated by the ionophore carbonyl
cyanide 3-chlorophenylhydrazone (CCCP) before n-
octane was added to the cells to form a biphasic mixture
saturated with n-octane. After incubating the cells withFigure 3 Schematic diagram demonstrating the protocols for efflux a
performed in the acrB-inactivated E. coli strain JA300A transformed with th
substantial uptake of n-octane. Resuspension of the cells in assay buffer co
n-octane content was quantified by GC-MS to determine the efflux rate. Di
These mutants were assayed using the same method except the cells were
plasmids harboring acrB mutants. The cultures containing cells expressing
1-octanol. As inferior mutants were killed by the hydrocarbons, the popula
tolerance. The plasmid mixtures were isolated after enrichment for efflux an-octane for uptake, the cells were resuspended in a
buffer with glucose to reactivate AcrB. The cells were
pelleted at regular time intervals and subjected to
chloroform extraction to recover intracellular n-octane,
which was subsequently quantified by gas chromatog-
raphy analyses. The change in intracellular n-octane
content over time was curve-fitted as a first-order
process to estimate the rate constants for n-octane re-
lease (Figure 4) [8]. The efflux rate of n-octane by AcrB
was calculated by taking the difference between the
n-octane release rate constants of JA300A/pMW119 (ex-
pressing no AcrB) and JA300A/pAcrB (expressing wild-
type AcrB) (Table 1).
Growth enrichment of mutant libraries and selection
based on determination of efflux rates
Eight mutant libraries of acrB were generated by muta-
genic PCR and cloned into pMW119. Each library
consisted of approximately 20,000 variants and had assay and competitive growth enrichment. (a) Efflux assay was
e plasmids of interest. Expressed AcrB were inactivated to allow
ntaining glucose reactivated the cells and the change in intracellular
screte clones were isolated from libraries with improved AcrB mutants.
cultivated from single colonies. (b) JA300A was transformed with
a mixture of AcrB variants were grown in the presence of n-octane or
tion became enriched with superior AcrB that conferred increased
ssay.
Figure 4 Change of intracellular n-octane with time in JA300A/
pMW119 (Δ) and JA300A/pAcrB (○). Intracellular n-octane content
has been normalized to the respective initial mass in mg.
Table 1 Rates of n-octane and α-pinene efflux from JA300A e
Hydrocarbons AcrB variants Hydrocarbon release rate
constant/min-1
n-octane none 0.227 ± 0.007
Wild-type 0.312 ± 0.010
1G1 0.352 ± 0.011
1G2 0.349 ± 0.009
N189H 0.318 ± 0.018
L357Q 0.290 ± 0.011
T678S 0.318 ± 0.025
T678A 0.334 ± 0.015
Q737L 0.355 ± 0.023
M844L 0.325 ± 0.010
M844A 0.339 ± 0.015
M987T 0.292 ± 0.019
V1028M 0.304 ± 0.008
α-pinene none 0.282 ± 0.018
Wild-type 0.297 ± 0.014
1G1 0.342 ± 0.015
1G2 0.328 ± 0.018
N189H 0.322 ± 0.012
L357Q 0.296 ± 0.009
T678S 0.319 ± 0.008
T678A 0.330 ± 0.012
Q737L 0.340 ± 0.008
M844L 0.318 ± 0.008
M844A 0.327 ± 0.019
M987T 0.293 ± 0.005
V1028M 0.297 ± 0.005
a Calculated by taking the difference between the hydrocarbon release rate constan
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ation 1.9). Library enrichment was initially performed
using n-octane. Each library was transformed into
JA300A and grown. The pre-culture containing a pool
of acrB variants being expressed at basal level was
subjected to the growth enrichment condition as de-
scribed for n-octane. After two additional rounds of sub-
cultivation for enrichment, the plasmid mixture for each
library was isolated (Figure 3b).
To facilitate rapid selection of improved AcrB from
the enriched libraries in the absence of a high-
throughput method for measuring efflux rate of n-
octane, the enriched libraries were preliminarily assayed
as variant mixtures to identify the pools with AcrB mu-
tants that improved extrusion of n-octane. Discrete
clones could then be isolated from these pools for fur-
ther assay and final selection. Thus, the plasmids of the
eight enriched libraries were transformed into JA300Axpressing AcrB variants
AcrB hydrocarbon efflux rate
constanta/min-1



























ts of JA300A expressing no AcrB and JA300A expressing variants of AcrB.
Figure 5 Expression levels of AcrB variants. M, marker; lane 1,
wild-type AcrB; lane 2, 1G1; lane 3, 1G2; lane 4, negative
control (pMW119).
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pool of AcrB variant mixture.
However, the rates of n-octane release for the libraries
were observed to be similar to that of wild-type AcrB.
Sequencing of five discrete clones isolated from a library
revealed mutations in the lac operator in four clones,
even though this region was not subjected to random
PCR mutagenesis. This could have arisen because AcrB
variants had to be expressed only at basal level for
growth selection to maintain sensitivity to n-octane such
that growth improvement of cells with superior AcrB
mutants would be apparent. Consequently, clones with
spontaneous mutations in the lac operator would have
conferred constitutive expression of AcrB, thus provid-
ing increased tolerance of n-octane and growth advan-
tage over cells expressing AcrB at basal level under
the regulation of wild-type lac operator. As a result,
the libraries were dominated by plasmids with mutant
lac operator expressing AcrB variants with average per-
formance rather than AcrB mutants with improved
efflux efficiency expressed from wild-type lac operator.
Clearly, n-octane could not apply sufficient selection
pressure to enable differentiation of variants with good
performance from the average ones. To overcome this
limitation, we directed our effort towards growth enrich-
ment using 1-octanol.
In contrast to selection conditions with n-octane, AcrB
expression was induced with IPTG before and during
growth enrichment with 1-octanol to overcome the
higher toxicity to E. coli compared to n-octane. After
two rounds of sub-cultivation, the enriched plasmid
mixture was purified and the variants were assayed for
n-octane release rate. Two of the eight enriched libraries
contained variants with enhanced n-octane efflux effi-
ciency. Five discrete clones were isolated from each of
the two libraries. Sequencing of the acrB mutants identi-
fied only one variant from each library and no mutation
was found in the lac operator for both variants. This re-
sult indicates that the selection pressure from the
growth enrichment conditions effectively eliminated less
tolerant cells harboring less efficient AcrB mutants.
These two AcrB variants are hereafter designated 1G1
and 1G2. The plasmids containing the genes are named
p1G1 and p1G2, respectively. The mutations in 1G1 are
N189H and T678S, and those in 1G2 are L357Q,
Q737L, M844L, M987T, V1028M.
Characterization of AcrB variants and structural analysis
JA300A harboring p1G1 and p1G2 were cultivated from
single colonies and induced with IPTG to express the
AcrB mutants. The growth rates of the cells in the pres-
ence of 1-octanol and the efficiency of the AcrB variants
in effluxing n-octane were investigated. Both 1G1- and
1G2-expressing JA300A showed significantly fastergrowth rates in the presence of 1-octanol, reaching
OD600 of 2.90 and 1.48, respectively, compared to 1.05
of wild-type AcrB after 48 h of growth (Figure 1b). The
variants also exhibited over 40% increase in n-octane ef-
flux rate relative to wild-type AcrB (Table 1). To exam-
ine the possibility that improvements in performance
were due to increased AcrB expression of the mutants,
western blotting was performed to compare the AcrB
expression levels between the variants. Constructs of
pAcrB, p1G1 and p1G2 with hexahistidine-tags inserted
at the C-termini were synthesized, and the proteins
expressed with IPTG induction were probed using anti-
hexahistidine antibodies. There was negligible difference
in the expression levels of 1G1 and 1G2 compared to
wild-type AcrB (Figure 5), indicating that the increased
efflux of n-octane and enhanced tolerance of the cells
expressing 1G1 and 1G2 were due to improved perform-
ance of the mutant proteins. Thus, we have demon-
strated successful isolation of AcrB mutants with
improved n-octane efflux efficiency from a competitive
growth selection based on 1-octanol tolerance.
Single-site mutants of the seven mutations identified
in 1G1 and 1G2 were generated to investigate their indi-
vidual effects on n-octane efflux (Table 1). L357Q,
M987T, V1028M showed reduced rate of n-octane ex-
trusion. Q737L and M844L increased the rate of n-
octane efflux by 51 and 15%, respectively. Interestingly,
N189H and T678S improved efflux of n-octane only
slightly (less than 10%) although 1G1, which possess
these two mutations, exhibited 47% faster efflux of n-
octane. These results suggest that N189H and T678S
may work synergistically.
To gain structural-functional insights of the seven mu-
tations in 1G1 and 1G2, the positions of the amino acid
substitutions were located on a known asymmetric
structure of AcrB (PDB ID: 2DHH) [21]. Analysis of
the structure shows that L357Q, M987T, V1028M were
in the transmembrane domain at locations unlikely
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lowered n-octane efflux rates of the single-site mutants
relative to wild-type AcrB. An overview of the positions
of N189, T678, Q737 and M844 on the structure of
AcrB is illustrated in Figure 6 using the protomer with
the “Access” conformation. N189H and Q737L are lo-
cated near the hairpins in the TolC docking domains
(Figure 6a), which are responsible for interaction with
TolC to form an AcrB-TolC complex [22]. This inter-
action is important to facilitate transfer of substrates
from AcrB to TolC for exportation out of the cell via the
TolC channel. The exact mechanism how N189H and
Q737L promotes efflux of n-octane is unclear. However,
the proximity of the two mutations to the hairpins in
the TolC docking domains suggests they might assist the
assembly of the AcrB-TolC complex. Particularly, Q737
is in the vicinity of a hairpin on the adjacent protomer,
thus the shortening of the side chain due to Q737L
might stabilize or improve the assembly or interactions
between AcrB and TolC for efficient export of n-octane.Figure 6 Structural analysis of the mutations at N189, T678, Q737 an
was used. In (a), N189 and Q737 (in blue) are near the hairpins (in red) tha
vicinity of a hairpin on the adjacent protomer (in dark gray). In (b), T678 an
substrate path leading to the binding pocket are colored yellow [24,25]. Th
proximity to M844 and flank residues in the substrate path (D681, R717 and
which is part of the vestibule leading to the binding pocket.T678S and M844L occur close to each other along
two proposed transport paths i.e. the vestibule between
protomers and the cleft in the periplasmic domain
(Figure 6b) [23,24]. Analysis of the structure of AcrB,
which shows functional rotation of the protomers,
revealed that T678 is near the entrance at the lower cleft
in the periplasmic domain leading to the binding pocket
of AcrB and exhibits large displacement when tran-
sitioning between the “Access”, “Binding” and “Extru-
sion” conformations (Additional file 1: Figure S2) [21].
In the “Extrusion” conformation, T678, which is in the
PC2 subdomain, is extremely close to N667 (2.6 Ǻ) in
the PC1 subdomain as the entrance is closed off. The
distance between T678 and N667 increases as the en-
trance opens to allow substrate access into AcrB when
the conformation transitions to “Access” and “Binding”,
before closing off the entrance again to assume the
“Extrusion” conformation. Thus, we propose that short-
ening the side chain of threonine in the T678S mutant
would likely widen the entrance at the lower cleft in thed M844 (PDB ID: 2DHH). The “Access” conformation of the structure
t interact with TolC to form the AcrB-TolC complex. Q737 is in the
d M844 are shown in blue. Residues that were reported to be in the
e amino acids F682, V716 and I827 (shown in pink) are in close
L828). M844 is also on the same α-helix as E842 (shown in green)
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cess time into the binding pocket for extrusion. The role
of M844L is less obvious. M844 is on the same α-helix
as E842 that has been identified as one of the residues
lining the vestibule leading to the binding pocket [23],
thus mutation to a leucine might cause a conformational
change that facilitates hydrocarbon entry into the trans-
port channel through the vestibule. Additionally, the side
chain of M844 is pointing in the opposite direction of
the vestibule towards adjacent loops bearing D681,
R717, L828 that line another channel to the binding
pocket in the cleft [23-25]. In fact, it is in close proxim-
ity to F682, V716 and I827 (3.9-4.3Ǻ) that flank D681,
R717 and L828, respectively (Figure 6b). Incidentally,
M844 is located in the PC2 subdomain of AcrB in a re-
gion that exhibits large conformational changes during
the displacement of the drug doxorubicin [26]. It is pos-
sible that the shorter side chain of leucine causes distal
conformational changes that re-position D681, R717 and
L828 such that the channel leading to the binding
pocket is enlarged or the dynamics of substrate efflux is
altered. This phenomenon has been observed in other
proteins [27,28]. Crystal structures would be required to
validate these hypotheses. Nevertheless, these proposi-
tions on the roles of the T678S and M844L mutations
are supported by the increased n-octane efflux by the
T678A and M844A variants (Table 1), which have the
side chains shortened to a methyl group. The effect of
T678A is also consistent with the observation that in-
creasing the bulk of residue A677, which is adjacent to
T678, reduced drug efflux [25].
To investigate the ability of 1G1, 1G2 and the single-
site mutants in effluxing biofuels that are structurally
dissimilar to 1-octanol and n-octane, which are con-
formationally flexible linear compounds, we chose a cyc-
lic and conformationally more rigid biofuel candidate, α-
pinene, as the test substrate. The rate of α-pinene release
was assayed (Table 1) and interestingly, the mutants that
improved efflux of n-octane also enhanced the efflux
rate of α-pinene (Table 1) despite the structural dissimi-
larity of the substrates (Figure 7). This suggests that
the beneficial effects of the mutations are not specific
to 1-octanol and n-octane only, but may be generallyFigure 7 Structures of hydrocarbons used in this work.important for improving efflux of small hydrophobic
hydrocarbon molecules.
Three known antibiotic substrates of AcrB [29] of
varying molecular weight – nalidixic acid (232.24 g mol-1),
chloramphenicol (323.13 g mol-1) and tetracycline (444.44
g mol-1) – were chosen to investigate the antibiotic resist-
ance of the mutants that improved n-octane efflux (i.e.
1G1, 1G2, N189H, T678S, T678A, Q737L, M844L and
M844A). Interestingly, none of the mutants showed in-
creased antibiotic resistance towards the antibiotics.
JA300A expressing wild-type and AcrB mutants have
minimum inhibitory concentrations (MICs) of 5.0, 5.0
and 1.0 mg/L for chloramphenicol, nalidixic acid and
tetracycline, respectively. The MICs for the control strain
(JA300A with pMW119) towards chloramphenicol, nali-
dixic acid and tetracycline are 1.5, 1.5 and 0.1 mg/L, re-
spectively. The neutral effect of the mutations towards
antibiotic resistance could be because the mechanisms
for extrusion of antibiotics and small hydrophobic mol-
ecules are different. For example, substrate recognition
through interactions between amino acids in the trans-
port pathway of AcrB and the polar functional groups in
antibiotics is required for antibiotic efflux [21] whereas
such interactions are absent with small hydrophobic mole-
cules. Nevertheless, it is advantageous that the mutations
beneficial for n-octane efflux do not increase antibiotic re-
sistance because that would eliminate the possibility of
generating pathogenic bacteria with high antibiotic resist-
ance. This would be particularly important if strains with
the mutant AcrBs were used in large volumes for mass
production of hydrocarbons.
Conclusions
A ‘competitive growth’-based selection strategy was devel-
oped in this study for rapid isolation of AcrB mutants with
improved efflux efficiency of n-octane. Although the crys-
tal structure and substrate path of AcrB are known, the
mechanism of AcrB involves a highly dynamic peristaltic
action and functional rotation between the protomers
[21]. Therefore, we chose directed evolution over rational
design to engineer AcrB because it could enable discovery
of variants with mutations that would not have been obvi-
ous enough to be identified. Indeed, with the exception of
T678S which lies in the substrate path, the other amino
acid changes that benefit n-octane efflux, i.e. N189H,
Q737L and M844L, are distant from the substrate path.
We reasoned that these mutations may improve substrate
efflux by enlarging the substrate path, altering the sub-
strate efflux dynamics and facilitating the assembly of the
AcrB-TolC complex. These mutations are also beneficial
for effluxing other small hydrophobic molecules, as illus-
trated by the increased extrusion rate of α-pinene.
We successfully engineered AcrB for enhanced efflux
efficiency of n-octane by competitive growth selection
Foo and Leong Biotechnology for Biofuels 2013, 6:81 Page 9 of 12
http://www.biotechnologyforbiofuels.com/content/6/1/81for tolerance towards the more toxic substrate surrogate,
1-octanol. This strategy of employing a toxic substrate
surrogate for competitive growth enrichment is particu-
larly beneficial for engineering efflux pumps to accelerate
extrusion of biofuel with low toxicity, such as n-octane
and higher alkanes [8], since mildly toxic compounds
could not select for AcrB mutants effectively for enhanced
efflux. These improved AcrB can now be used to improve
the yield of biofuel production and/or increase cell toler-
ance to the synthesized hydrocarbon [9]. The next step
forward would be to validate the use of these mutant
pumps in engineered bacterial systems that biosynthesize
small biofuel molecules such as n-octane and α-pinene
in vivo. Much efforts are currently focused on metabolic
engineering activities for biofuel production in microbes
[1-6] and we expect the outcome of this work to underpin
the development of scalable microbial platforms for
biofuels production.
Methods
Strains, plasmids, oligonucleotides, chemicals and culture
media
E. coli XL10-Gold {(Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)
173 endA1 supE44 thi-1 recA1 gyrA96 relA1 lac Hte [F’
proAB lacIqZ Δ15 Tn10 (Tetr) Tn5 (Kanr) Amy]}
(Stratagene) was the host strain used for plasmid con-
struction. JW0451-2 [F-, Δ(araD-araB)567, ΔlacZ4787(::
rrnB-3), ΔacrB747::kan, λ-, rph-1, Δ(rhaD-rhaB)568,
hsdR514] strain and P1vir phage were purchased from
The Coli Genetic Stock Center (Yale University, USA).
JA300 (F- thr leuB6 trpC1117 thi rpsL20 hsdS) strain
was obtained from ATCC. Its acrB-inactivated deriva-
tive, JA300A, was generated by P1vir phage transduction
[30] with JW0451-2. JA300A was used for library enrich-
ment, hydrocarbon resistance studies and efflux assays.
acrB gene was cloned from the E. coli strain W3110 [F- IN
(rrnD-rrnE)1]. The low-copy-number vector pMW119
(WAKO Pure Chemical Industries, Osaka, Japan) was
used for cloning and expression under the control of the
lac promoter. Oligonucleotides were synthesized by 1st
Base (Singapore) and the sequences are shown in Add-
itional file 1: Table S1. All chemicals were purchased from
Sigma-Aldrich (Singapore) and of purity higher than 98%.
Lysogeny broth (LB) consisting of 1% tryptone, 0.5%
yeast extract and 1% NaCl was used for cell cultivation.
Where appropriate, ampicillin (100 μg/mL) and/or IPTG
(0.1 mM) were added to the medium. Hereafter, LBA
and LBI refers to LB medium supplemented with ampi-
cillin and IPTG, respectively, and LBAI refers to LB
medium with both ampicillin and IPTG added.
DNA manipulation
Standard techniques were used for DNA manipulation,
including isolation and purification of plasmids andDNA fragments, agarose gel electrophoresis, restriction
enzyme digestion, ligation and transformation of E. coli
[31]. All restriction enzymes and DNA-modifying en-
zymes were purchased from Fermentas (Singapore).
Cloning of acrB
acrB was amplified from W3110 chromosomal DNA by
PCR using the primers acrB-F and acrBCln-R, which
contain the BamHI and SacI restriction sites, respect-
ively. The 3.2-kb PCR fragment was digested with
BamHI and SacI and the restricted DNA was cloned into
the 4.2-kb vector pMW119 to generate the 7.4-kb plas-
mid pAcrB. The sequence of the cloned acrB was veri-
fied by DNA sequencing.
Study of growth inhibition by n-octane and 1-octanol
pMW119 and plasmids of acrB variants were transformed
into electrocompetent JA300A. Overnight cultures of the
strains were diluted in 3 mL LB medium to OD600~0.03.
To study the growth inhibition of cells by n-octane, the di-
luted cells were shaken at 37°C with 1 mL n-octane, both
in the presence and absence of 0.1 mM IPTG, and the
OD600 was measured hourly. The growth inhibition of the
strains by 1-octanol was performed similarly with 0.025%
and 0.050% (v/v) 1-octanol in LBI medium and OD600
absorbance was measured every 24 h. Cultures without n-
octane and 1-octanol were grown in parallel as controls.
Competitive growth studies
JA300A was transformed with either pMW119 or pAcrB.
Overnight cultures of the two strains were grown separ-
ately and mixed in a 1:1 ratio. A 400 μL aliquot of the
mixed cells was inoculated into 20 mL of LB medium and
split into two 10 mL portions. To one of the portions, 3
mL of n-octane was added. Both cultures were grown
overnight at 37°C with shaking and subcultivated by 50-
fold dilution in the respective growth media. After two
more rounds of subcultivating, 200 μL of the final cultures
served as inoculum for 10 mL of LBA medium. Plasmids
were isolated from the overnight cultures for agarose gel
electrophoresis after BamHI digestion.
For competitive growth study with 1-octanol, two 10
mL portions of mixed cells were similarly prepared except
LBI medium was used. 1-Octanol was added to one of the
portions to a final concentration of 0.05% and both cul-
tures were grown for 2 days at 37°C with shaking. After
another round of subcultivating, the cells were diluted 50-
fold in LBA medium and grown for plasmid isolation. The
plasmids were subsequently digested with BamHI and an-
alyzed by agarose gel electrophoresis.
Mutant library construction
Mutagenic PCR was performed to introduce random
mutations into the acrB gene. Eight 50 μL PCR reaction
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reaction consisted of 10 ng of pAcrB as template, 0.2
μM of each primer acrB-F and acrB-R, 0.2 mM dATP,
0.2 mM dGTP, 1 mM dCTP, 1 mM dTTP, 10 mM Tris–
HCl (pH 8.8), 50 mM KCl, 0.08% (v/v) Nonidet P40, 7
mM MgCl2, 1 μL DMSO, 5 U Taq DNA polymerase
(Fermentas). The thermocycling program used consisted
of an initial denaturation at 94°C for 2 min, followed by
20 cycles of denaturation at 94°C for 10 s and concur-
rent annealing and extension at 72°C for 210 s. The PCR
products were restricted with BamHI and SacI and
cloned into pMW119, effectively generating eight mu-
tant libraries. The ligated products were recovered by
transformation into electrocompetent XL-10 Gold and
isolation of the plasmid mixtures from cells cultured in
LBA medium. Mutation rates of the libraries were deter-
mined by plating 10 μL of the initial transformants on
LBA-agar plates and sequencing plasmids isolated from
10 random single colonies picked from the plates.
Competitive growth enrichment of mutant libraries with
n-octane and 1-octanol
The purified mutant library plasmid mixtures were
transformed into electrocompetent JA300A. After 1 h of
outgrowth, a pre-culture was prepared by growing the
transformants overnight in 10 mL of LBA medium at
37°C with continuous shaking.
For growth enrichment with n-octane, a 200 μL ali-
quot of the pre-culture was inoculated into 10 mL of LB
medium saturated with a 3-mL overlay of n-octane, and
shaken overnight at 37°C. The cultures were enriched by
two more rounds of sub-culturing.
For growth enrichment with 1-octanol, a 200 μL ali-
quot of culture was inoculated into 10 mL of LBAI
medium. The cells were grown overnight with shaking
at 37°C to induce expression of AcrB. The overnight cul-
ture served as inoculum for 10 mL of LBI medium with
0.05% of 1-octanol. This culture was grown at 37°C with
shaking for 2 days. The cultures were subcultivated once
more for enrichment.
To isolate plasmid DNA from the enriched libraries, a
200 μL aliquot of the final enrichment culture was inoc-
ulated into 10 mL of LBA medium and the cells were
grown overnight at 37°C for miniprep. The enriched li-
brary DNA was transformed into XL-10 Gold and plated
on LBA agar. Plasmids of discrete clones were isolated
from cultures grown from single colonies picked from
the plate of cells and sequenced (Figure 3b).
Assay for rate of hydrocarbon release from E. coli
The rate of hydrocarbon release from E. coli cells were
determined by adapting published methods [8,16]. Pre-
cultures of JA300A cells transformed with various plas-
mids were prepared. For preliminary assays of enrichedacrB libraries, the pre-culture was prepared by transform-
ation of the mixture of plasmids into electrocompetent
JA300A cells and growing the cells overnight in 10 mL
LBA medium after 1 h of outgrowth. For assays of individ-
ual variants, cells for the pre-cultures were grown from a
single colony of JA300A transformed with the plasmid
picked from an LBA agar plate.
The pre-cultures were diluted 50-fold with 10 mL LBAI
medium and grown for 16 h at 37°C. The cells were
washed thrice by centrifugation (2000g, 3 min) and
resuspended in 10 mL PPB (20 mM sodium phosphate pH
7 and 1mM MgCl2). After another centrifugation cycle to
pellet the cells, the cells were resuspended in 10 mL PPB
at OD600~1.5. Carbonyl cyanide 3-chlorophenylhydrazone
(10 mM stock solution in DMSO) was added to the cells
to a final concentration of 10 μM and the cell suspensions
were shaken at 160 rpm for 15 min at 37°C. n-Octane or
α-pinene (0.5 mL) was added to each sample and the bi-
phasic mixture was further shaken at 200 rpm for 1 h at
37°C. The cells were then pelleted at 2000g for 3 min.
The supernatant and hydrocarbon were carefully and
thoroughly aspirated. The cells were resuspended in 10
mL PPB with 50 mM glucose, then incubated at 37°C
and shaken at 160 rpm. One milliliter aliquots were
transferred into microcentrifuge tubes in duplicate peri-
odically (0-7min). The cell aliquots were immediately
centrifuged (21000 g, 1 min) and the supernatant was
removed. The cell pellets were resuspended in 500 μL
dH2O before extraction with 750 μL CHCl3 for 3 h.
The organic extracts were removed and analyzed by
gas chromatography-mass selective detector (GC-MS).
(Figure 3a).
Site-directed and insertional mutagenesis
Single-site N189H, T678A, Q737L and M844A acrB mu-
tants were generated from pAcrB using the QuikChange
(Stratagene) protocol for site-directed mutagenesis. The
primers used were as follow: N189H-F, N189H-R for
N189H acrB; T678A-F, T678A-R for T678A acrB; Q737L-
F, Q737L-R for Q737L acrB; M844A-F, M844A-R for
M844A acrB. The PCR reaction mixtures consisted of 20
ng pAcrB, 200 μM dNTP, 1.75 mM MgSO4, 1 μL DMSO,
1 U KOD Hot Start DNA polymerase (Novagen), 0.3 μM
mutagenic primers and 5 μL 10x KOD Hot Start DNA
polymerase PCR buffer made up to 50 μL with deionized
water. The reaction mixtures were subjected to an initial
denaturation at 95°C for 2 min, followed by 20 cycles of
denaturation at 95°C for 20 s, annealing at 60°C for 20 s
and extension at 70°C for 240 s.
Hexahistidine-tags were added to the C-termini of
acrB genes by appending four histidines to the two that
are naturally present in protein via insertional mutagen-
esis [32]. PCR mixtures consisting of 20 ng plasmid tem-
plates, 200 μM dNTP, 1.75 mM MgSO4, 1 μL DMSO, 1
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of mutagenic primers acrBHis-F and acrBHis-R each
and 5 μL 10x KOD Hot Start DNA polymerase PCR buf-
fer made up to 50 μL with deionized water were pre-
pared. The reaction mixtures were subjected to an initial
denaturation at 95°C for 2 min, followed by 15 cycles of
denaturation at 95°C for 20 s, annealing at 50°C for 20 s
and extension at 70°C for 210 s.
To isolate plasmids of the mutants, the PCR mixtures
were digested with DpnI at 37°C for 3 h and transformed
into electrocompetent XL-10 Gold cells. The cells were
plated onto LBA agar and incubated at 37°C overnight.
Cells were grown from single colonies and plasmids
were isolated by miniprep kit. Mutations were verified
by sequencing.
Immunoblot analysis
Cells expressing hexahistidine-tagged AcrB were culti-
vated as described for assaying the rate of hydrocarbon
release. The OD600 of the cultures were adjusted to 1.0,
and 1-mL aliquots of the cells were centrifuged (21000g,
2 min). The cell pellets were resuspended in a buffer
containing 20 mM Tris–HCl (pH 8.0), 5 mM EDTA, 8
M urea, 10 mM phenylmethanesulfonyl fluoride and 2%
sodium dodecyl sulfate, and shaken gently at room
temperature for 1 h to lyse the cells and solubilize AcrB.
The lysates were mixed with an equal volume of 2x
loading dye (Sigma-Aldrich) and incubated at 37°C for
10 min before being analyzed by SDS-PAGE. The pro-
teins were transferred to polyvinylidene fluoride mem-
branes (Bio-Rad) electrophoretically and probed using
anti-hexahistidine antibody conjugated with horse rad-
ish peroxidase. The hexahisitidine-tagged AcrBs were
detected colorimetrically on the membrane using
3,3’,5,5’-tetramethylbenzidine.
Antibiotic resistance assay
JA300A harboring pMW119 and plasmids with genes
for wild-type, 1G1, 1G2, N189H, T678S, T678A, Q737L,
M844L and M844A acrB were grown overnight in LBA
at 37°C with shaking at 200 rpm. Approximately 103
cells were added to LB with various concentrations of
chloramphenicol (0.5-10 mg/L), nalidixic acid (0.5-10
mg/L) and tetracycline (0.05 - 3mg/L) in 96-well micro-
titre plates and grown at 37°C with shaking at 200 rpm
for 20 h. The MIC is the lowest antibiotic concentration
that inhibited growth. Triplicated experiments gave con-
sistent MIC.
Structural analysis
The locations of the mutations were studied on a
published structure of AcrB (PDB ID: 2DHH). Ren-
dered images of protein structures were generated
with Pymol [33].Additional file
Additional file 1: Table S1. Sequences of oligonucleotides used in this
work. Figure S1. Effect of 100 μM IPTG on the growth of JA300A/
pMW119 (triangle) and JA300A/pAcrB (circle). The growth of the strains
were not appreciably affected by the presence (filled symbols, solid lines)
and absence (open symbols, dashed lines) of 100 100 μM IPTG.
Figure S2. Positions of T678 in different conformations of AcrB (PDB
ID: 2DHH). As AcrB cycles through the (A) “Extrusion”, (B) “Access”
and (C) “Binding” conformations during functional rotation, the
position of T678 varies significantly. T678 is extremely close to N667
in the PC1 domain in the “Extrusion” conformation but the distance
between the residues increases in the “Access” and “Binding”
conformation to allow substrate entry into AcrB.
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LBA: LB supplemented with ampicillin; LBI: LB supplemented with IPTG;
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